S&P 500 7,512 -0.42% Nasdaq 25,853 -0.97% Dow Jones 52,288 -0.42% FTSE 100 10,586 +0.54% DAX 25,011 -0.54% Nikkei 225 66,232 -2.23% Hang Seng 25,132 +3.25% WTI Crude 84.23 +6.69% Gold 4,083 +2.44% US 10-Year Treasury Yield 4.626 +1.78% S&P 500 7,512 -0.42% Nasdaq 25,853 -0.97% Dow Jones 52,288 -0.42% FTSE 100 10,586 +0.54% DAX 25,011 -0.54% Nikkei 225 66,232 -2.23% Hang Seng 25,132 +3.25% WTI Crude 84.23 +6.69% Gold 4,083 +2.44% US 10-Year Treasury Yield 4.626 +1.78%

LATEST

Jack Mallers Quits Twenty One Capital as Tether's Bitcoin Merger Collapses●How to work with a credit card debt collector●MEXC adds Bittensor TAO staking for its global user base●Houthi Threats Ignite New Oil Price Surge●‘Pasta windows’: a charming Italian restaurant tradition – or the sign of a terrible tourist trap?●Turkish readywear retailer Koton’s stock damaged by Ukrainian bombing of Wildberries warehouses in Russia●The gas blamed for warming the planet is about to be used to store Ireland’s renewable electricity.●Delaware judge dismisses UnitedHealth Group lawsuit against the Guardian●Jack Mallers Quits Twenty One Capital as Tether's Bitcoin Merger Collapses●How to work with a credit card debt collector●MEXC adds Bittensor TAO staking for its global user base●Houthi Threats Ignite New Oil Price Surge●‘Pasta windows’: a charming Italian restaurant tradition – or the sign of a terrible tourist trap?●Turkish readywear retailer Koton’s stock damaged by Ukrainian bombing of Wildberries warehouses in Russia●The gas blamed for warming the planet is about to be used to store Ireland’s renewable electricity.●Delaware judge dismisses UnitedHealth Group lawsuit against the Guardian●

Wealth

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

MarketWatch.com - Top Stories · 4h ago · 🇺🇸 United States

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Read the full story at MarketWatch.com - Top Stories →

More Wealth

Why Paramount could win if it loses the Warner Bros. Discovery deal

MarketWatch.com - Top Stories · 1h ago

Tesla earnings are on deck, and investors will be looking to settle this major debate

MarketWatch.com - Top Stories · 1h ago

If timing the stock market were easy, the Iran war would have proven it. It’s done the opposite.

MarketWatch.com - Top Stories · 2h ago

Welcome to the ‘Roaring ’20s’: Here’s how this earnings season will keep the bull market strong

MarketWatch.com - Top Stories · 2h ago